Company News
Company News
- MINVASYS created in May 2003 is an international privately held company based in the Paris area, France.
- MINVASYS focuses on bifurcation treatment with dedicated devices. Nile Croco® for coronary bifurcations and Twin-One® for carotid bifurcations.
- MINVASYS received Conformity Europeenne (CE) Mark approval for its Nile Pax® Polymer Free Drug Eluting Stent (DES) system, the first DES dedicated to coronary bifurcation treatment. This CE Mark approval has been granted by the LNE (French Notified Body) and AFSSAPS (French Health Authority) according the new European Union directive 2007/47/EC. This technology combines the latest innovations in stent and molecule designing.
A microdrop sprayed crystallization process allows a pure paclitaxel elution directly applied onto the abluminal side of the stent.
- MINVASYS has initiated animal trials on Drug Eluting Balloon with our Polymer Free Paclitaxel Abluminal Technology.
Read more
Innovations & Current Products
Innovation
- Pax Technology®, Polymer Free Palictaxel Elution applied on our utmost Croco® stent generation. It's a propriatery microdrop spray process applying a thin homogeneous layer of pure paclitaxel (5µ) on abluminal side of the stent.
Current products
- Nile Croco®, when treating coronary bifurcation becomes as simple as conventional stenting procedures. New stent size (24mm) and news balloon combinations have been recently added, offering more therapeutical options to treat bifurcation.
- Amazonia Croco®. An extensive range combining new stent sizes (from 28 to 40mm) and new diameters (4.00 and5.00) have been recently added, making Amazonia Croco® range one the most complete currently available to treat your patients with a single stent. Its specific design ensures an efficient scaffolding maintaining an easy side branch access .
- SuperKetch® inflation kit. First and the original vascular access system designed for a single-hand use has been completed with a high pressure friendly-used inflation device.
Read more
